Revive Therapeutics Ltd (TSE:RVV)
CNQX:RVV
Holding TSE:RVV?
Track your performance easily

Revive Therapeutics (RVV) Financial Statements

127 Followers

Revive Therapeutics Financial Overview

Revive Therapeutics's market cap is currently ―. The company's EPS TTM is C$-0.011; its P/E ratio is -0.88; Revive Therapeutics is scheduled to report earnings on October 28, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue---C$ -340.17KC$ -65.21K
Gross Profit---C$ -340.17KC$ -65.21K
EBITC$ -1.87MC$ -764.72KC$ -383.14KC$ -1.18MC$ -1.94M
EBITDAC$ -1.87MC$ -764.64KC$ -383.06KC$ -1.18MC$ -1.94M
Net Income Common StockholdersC$ -1.87MC$ -770.62KC$ -390.62KC$ -1.18MC$ -1.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.05MC$ 708.41KC$ 1.59MC$ 2.09MC$ 2.66M
Total AssetsC$ 13.14MC$ 12.88MC$ 13.78MC$ 14.25MC$ 15.77M
Total DebtC$ 61.51KC$ 156.05KC$ 188.91KC$ 219.69KC$ 248.75K
Net DebtC$ -987.89KC$ -552.37KC$ -1.40MC$ -1.87MC$ -2.41M
Total LiabilitiesC$ 3.33MC$ 3.35MC$ 3.52MC$ 3.60MC$ 3.92M
Stockholders EquityC$ 9.82MC$ 9.53MC$ 10.26MC$ 10.65MC$ 11.85M
Cash Flow-
Free Cash FlowC$ -1.64MC$ -883.42KC$ -495.53KC$ -568.09KC$ -2.16M
Operating Cash FlowC$ -1.64MC$ -883.42KC$ -495.53KC$ -568.09KC$ -2.16M
Investing Cash FlowC$ -40.00K----
Financing Cash FlowC$ 2.02M---C$ 4.10M
Currency in CAD

Revive Therapeutics Earnings and Revenue History

Revive Therapeutics Debt to Assets

Revive Therapeutics Cash Flow

Revive Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis